New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
| dc.contributor.author | Dupuis, J. | |
| dc.contributor.author | Palmer, L. | |
| dc.date.issued | 2010 | |
| dc.description.abstract | Levels of circulating glucose are tightly regulated. To identify new loci influencing glycemic traits, we performed meta-analyses of 21 genome-wide association studies informative for fasting glucose, fasting insulin and indices of beta-cell function (HOMA-B) and insulin resistance (HOMA-IR) in up to 46,186 nondiabetic participants. Follow-up of 25 loci in up to 76,558 additional subjects identified 16 loci associated with fasting glucose and HOMA-B and two loci associated with fasting insulin and HOMA-IR. These include nine loci newly associated with fasting glucose (in or near ADCY5, MADD, ADRA2A, CRY2, FADS1, GLIS3, SLC2A2, PROX1 and C2CD4B) and one influencing fasting insulin and HOMA-IR (near IGF1). We also demonstrated association of ADCY5, PROX1, GCK, GCKR and DGKB-TMEM195 with type 2 diabetes. Within these loci, likely biological candidate genes influence signal transduction, cell proliferation, development, glucose-sensing and circadian regulation. Our results demonstrate that genetic studies of glycemic traits can identify type 2 diabetes risk loci, as well as loci containing gene variants that are associated with a modest elevation in glucose levels but are not associated with overt diabetes. | |
| dc.description.statementofresponsibility | Josée Dupuis ... Lyle J Palmer ... et al. | |
| dc.identifier.citation | Nature Genetics, 2010; 42(2):105-116 | |
| dc.identifier.doi | 10.1038/ng.520 | |
| dc.identifier.issn | 1061-4036 | |
| dc.identifier.issn | 1546-1718 | |
| dc.identifier.orcid | Palmer, L. [0000-0002-1628-3055] | |
| dc.identifier.uri | http://hdl.handle.net/2440/94294 | |
| dc.language.iso | en | |
| dc.publisher | Nature Publishing Group | |
| dc.rights | © 2010 Nature America, Inc. All rights reserved. | |
| dc.source.uri | https://doi.org/10.1038/ng.520 | |
| dc.subject | DIAGRAM Consortium | |
| dc.subject | GIANT Consortium | |
| dc.subject | Global BPgen Consortium | |
| dc.subject | Anders Hamsten on behalf of Procardis Consortium | |
| dc.subject | MAGIC investigators | |
| dc.subject | Humans | |
| dc.subject | Diabetes Mellitus, Type 2 | |
| dc.subject | Genetic Predisposition to Disease | |
| dc.subject | Blood Glucose | |
| dc.subject | Fasting | |
| dc.subject | Reproducibility of Results | |
| dc.subject | Gene Expression Regulation | |
| dc.subject | Homeostasis | |
| dc.subject | Quantitative Trait, Heritable | |
| dc.subject | Polymorphism, Single Nucleotide | |
| dc.subject | Alleles | |
| dc.subject | Quantitative Trait Loci | |
| dc.subject | Databases, Genetic | |
| dc.subject | Adolescent | |
| dc.subject | Adult | |
| dc.subject | Child | |
| dc.subject | Meta-Analysis as Topic | |
| dc.subject | Genome-Wide Association Study | |
| dc.subject | Genetic Loci | |
| dc.subject | DNA Copy Number Variations | |
| dc.subject | Delta-5 Fatty Acid Desaturase | |
| dc.title | New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk | |
| dc.type | Journal article | |
| pubs.publication-status | Published |